Works matching IS 02536269 AND DT 2024 AND VI 47 AND IP 10/11
Results: 5
Saponins as potential novel NLRP3 inflammasome inhibitors for inflammatory disorders.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 10/11, p. 757, doi. 10.1007/s12272-024-01517-x
- By:
- Publication type:
- Article
Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 10/11, p. 829, doi. 10.1007/s12272-024-01514-0
- By:
- Publication type:
- Article
Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 10/11, p. 812, doi. 10.1007/s12272-024-01513-1
- By:
- Publication type:
- Article
Ginsenoside Rg3 activates the immune function of CD8+ T cells via circFOXP1-miR-4477a-PD-L1 axis to induce ferroptosis in gallbladder cancer.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 10/11, p. 793, doi. 10.1007/s12272-024-01516-y
- By:
- Publication type:
- Article
Potential effects of a human milk oligosaccharide 6′-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway.
- Published in:
- Archives of Pharmacal Research, 2024, v. 47, n. 10/11, p. 854, doi. 10.1007/s12272-024-01515-z
- By:
- Publication type:
- Article